General Information of the Compound
| Compound ID |
CP0084320
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CAS_4394-00-7
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid
2-(3-(Trifluoromethyl)anilino)nicotinic acid
2-(3-Trifluoromethyl-phenylamino)-nicotinic acid
2-(3-Trifluoromethylanilino)nicotinic Acid
2-(3-[Trifluoromethyl]anilino)nicotinic acid
2-(A,A,A-Trifluoro-m-toluidino)nicotinic acid
2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid
2-[(3-TRIFLUOROMETHYL)PHENYL]AMINO-3-PYRIDINE-CARBOXYLIC ACID
2-[(3-Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid
2-[(3-Trifluoromethylphenyl)amino]nicotinic Acid
2-[3-(Trifluoromethyl)anilino]nicotinic acid
2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid
2-[alpha,alpha,alpha-trifluoro-m-toluidino]-nicotinic acid
2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID
2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid
39690A
Acid, Niflumic
Acide niflumique
Acide niflumique [French]
Acide niflumique [INN-French]
Acido niflumico
Acido niflumico [INN-Spanish]
Acido niflumico [Italian]
Acidum niflumicum
Acidum niflumicum [INN-Latin]
Actol
Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino
Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino [French]
Donalgin
Flunir
Forenol
Landruma
N 0630
NFL
Niflactol
Niflam
Niflugel
Niflugel (TN)
Niflumate
Niflumic Acid
Niflumic acid (INN)
Niflumic acid [INN:DCF]
Nifluminic acid
Nifluril
SC 1332
UP 83
UPSA Brand 1 of Niflumic Acid
UPSA Brand 2 of Niflumic Acid
UPSA Conseil Brand of Niflumic Acid
Upsamedica Brand of Niflumic Acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H9F3N2O2
|
||||||||||||||||||
| Molecular Weight |
282.221
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JZFPYUNJRRFVQU-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
4394-00-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03308, G-protein coupled receptor 35
Cell-based Assay
Protein ID: PT00901, Prostaglandin G/H synthase 2
Protein ID: PT06896, Transcription factor SOX-18
Protein ID: PT02311, UDP-glucuronosyltransferase 1A1
Clinical Information about the Compound